Abstract
Although some of palladium (Pd) complexes possess promising anti‐tumor activities, they are all chelated with N‐containing ligands and function by interacting with DNA. Few studies on the bio‐activities and mechanism of Pd‐O chelates have been conducted. In this study, a Pd complex containing four O‐donor ligands, Pd(acac)2, has been synthesized and evaluated as an anticancer agent. Solution stability test through 1H‐NMR spectra reveals that Pd(acac)2 maintained chemical stability being in the S‐donor containing DMSO solution. MTT assay shows that Pd(acac)2 exhibited significant cytotoxicity against BGC 823, HL‐60, KB, LS‐174T, and Hela cells. Flow cytometric assay reveals that treatment with Pd(acac)2 significantly induced apoptosis in H460 cells. Interestingly, gel electrophoresis and ultraviolet absorption assay show that Pd(acac)2 did not act directly on DNA. Immunoblotting assay indicates that the anti‐tumor effects of Pd(acac)2 are associated with ER stress‐mediated apoptosis pathway, followed by caspase activation. CHOP knockdown by specific siRNA significantly attenuated Pd(acac)2‐induced cell apoptosis, indicating that the apoptotic pathway is partly ER stress‐dependent. In summary, these data may provide us a novel mechanistic strategy for the development of metal‐based anticancer drugs.This work was supported by National Natural Science Funding of China (81102452).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.